PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Mebeverine hydrochloride - Muscle spasm

PAD Profile : Mebeverine hydrochloride - Muscle spasm

Keywords :
smooth muscle spasm, bowel colic, stomach cramps, muscle cramps, gastro intestinal muscle cramps, gastro intestinal antispamodics, irritable bowel syndrome, IBS
Brand Names Include :
Colofac

Traffic Light Status

Status 1 of 2.

Status :
Green
Important
Formulations :
  • Suspension
  • Tablets
Important Information :
Suspension not licensed in under 10 years. Tablets not licensed in children.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Green
Important
Formulations :
  • Capsules (slow release)
Important Information :
Capsules not licensed in children.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Generic mebeverine has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status Note - the branded product, Colofac, was considered BLACK by the May 2017 PCN

Associated BNF Codes

01. Gastro-Intestinal System
01.02.00. Antispasmodics and other drugs altering gut motility
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More